The Technical Analyst
Novan Inc [NOVN]
Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Novan Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-24.84% $0.0941
America/New_York / 25 jul 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2.64 mill |
| EPS: | -0.840 |
| P/E: | -0.112 |
| Earnings Date: | Aug 08, 2023 |
| SharesOutstanding: | 28.02 mill |
| Avg Daily Volume: | 1.037 mill |
| RATING 2023-08-21 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.112 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.02x |
| Company: PE -0.112 | industry: PE 5.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ -0.0470 - 0.159 ( +/- 183.93%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-06-27 | Sanders Machelle | Sell | 11 553 | Common Stock |
| 2023-06-06 | John A. Donofrio | Buy | 85 000 | Restricted Stock Units |
| 2023-06-06 | Gay John M. | Buy | 200 000 | Restricted Stock Units |
| 2023-06-07 | Gay John M. | Buy | 65 000 | Common Stock |
| 2023-06-06 | Gay John M. | Buy | 65 000 | Restricted Stock Units |
| INSIDER POWER |
|---|
| 60.98 |
| Last 97 transactions |
| Buy: 4 746 863 | Sell: 340 227 |
Forecast:
01:40 - $0.202
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0941 (-24.84% ) |
| Volume | 6.93 mill |
| Avg. Vol. | 1.037 mill |
| % of Avg. Vol | 668.48 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NOVN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NOVN
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
Latest Press Releases
2023-07-17 08:45:00 - Press Release
Novan Enters Into Agreement To Sell Substantially All Of Its Assets, Including Berdazimer Gel, 10.3% (sb206), And Files For Chapter 11 Protection
– the company and ligand pharmaceuticals sign agreement to sell substantially all of novan's assets under section 363 of the u.s. bankruptcy code, along with a commitment from ligand to fund $15 million in debtor-in-possession financing –
2023-05-08 09:05:00 - Press Release
Novan To Report First Quarter 2023 Financial Results On May 15, 2023
Durham, n.c., may 08, 2023 (globe newswire) -- novan, inc. (“the company” or “novan”) (nasdaq: novn), today announced that it will report its first quarter 2023 financial results on monday, may 15th. novan management will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 a.m. et that same day.
2023-03-23 09:00:00 - Press Release
Novan To Report Full Year 2022 Financial Results On March 30, 2023
Durham, n.c., march 23, 2023 (globe newswire) -- novan, inc. (“the company” or “novan”) (nasdaq: novn), today announced that it will report its full year 2022 financial results on thursday, march 30th. novan management will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 a.m. et that same day.
2023-03-14 08:30:00 - Press Release
Novan To Present At The Oppenheimer 33rd Annual Healthcare Conference
Presentation with live webcast today, march 14th at 10:40 am et presentation with live webcast today, march 14th at 10:40 am et
2023-01-18 08:05:00 - Press Release
Novan To Present At The Virtual Investor 2023 Companies To Watch Event
Live video webcast on thursday, january 19th at 12:00 pm et live video webcast on thursday, january 19th at 12:00 pm et
Latest News
2023-05-15 15:07:06 - Seeking Alpha
Novan, Inc. (NOVN) Q1 2023 Earnings Call Transcript
Novan, Inc. (NASDAQ:NOVN ) Q1 2023 Earnings Conference Call May 15, 2023 8:30 AM ET Company Participants Paula Brown Stafford - Chairman, President & Chief Executive Officer John Donofrio - Executive Vice President & Chief Operating Officer John Gay - Chief Financial Officer Conference Call Participants Oren Livnat - H.C. Wainwright Jeff Jones - Oppenheimer Jonathan Aschoff - Roth Capital Kemp Dolliver - Brookline Capital Markets John Vandermosten - Zacks Operator Hello and welcome to the Novan Inc. Quarterly Update Conference Call and Webcast.
2023-05-08 09:05:00 - GlobeNewsWire
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
DURHAM, N.C., May 08, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its first quarter 2023 financial results on Monday, May 15th. Novan management will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 a.m. ET that same day.
2023-03-23 09:00:00 - GlobeNewsWire
Novan to Report Full Year 2022 Financial Results on March 30, 2023
DURHAM, N.C., March 23, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its full year 2022 financial results on Thursday, March 30th. Novan management will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 a.m. ET that same day.
2023-03-14 08:30:00 - GlobeNewsWire
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
Presentation with live webcast today, March 14th at 10:40 AM ET Presentation with live webcast today, March 14th at 10:40 AM ET
2023-01-18 08:05:00 - GlobeNewsWire
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
Live video webcast on Thursday, January 19th at 12:00 PM ET Live video webcast on Thursday, January 19th at 12:00 PM ET
2022-11-15 02:40:02 - Seeking Alpha
Novan, Inc. (NOVN) Q3 2022 Earnings Call Transcript
Novan, Inc. (NASDAQ:NOVN ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Paula Brown Stafford - Chairman, President, and Chief Executive Officer John Gay - Chief Financial Officer John Donofrio - Chief Operating Officer and President, EPI Health Conference Call Participants Jeff Jones - Oppenheimer Jennifer Kim - Cantor Fitzgerald Kemp Dolliver - Brookline Capital Markets John Vandermosten - Zacks Operator Hello, and welcome to the Novan, Inc. Quarterly Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.
2022-08-11 22:29:11 - Seeking Alpha
Novan, Inc. (NOVN) CEO Paula Stafford on Q2 2022 Results - Earnings Call Transcript
Novan, Inc. (NASDAQ:NOVN ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Paula Stafford - President, CEO & Chairwoman John Gay - CFO & Corporate Secretary John Donofrio - EVP, COO & President, EPI Health Conference Call Participants Jeff Jones - Oppenheimer Brian Dolliver - Brookline Capital Markets Jonathan Aschoff - ROTH Capital Partners Oren Livnat - H.C. Wainwright & Co. John Vandermosten - Zacks Small-Cap Research Jennifer Kim - Cantor Fitzgerald & Co. Operator Hello, and welcome to the Novan, Inc. Quarterly Update Conference Call and Webcast.
2022-08-04 09:05:00 - GlobeNewsWire
Novan to Report Second Quarter 2022 Financial Results on August 11, 2022
DURHAM, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its second quarter 2022 financial results on Thursday, August 11th. Novan management will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 a.m. ET that same day.
2022-05-19 09:05:00 - GlobeNewsWire
Novan to Present Berdazimer Gel, 10.3% (SB206) Clinical Data at Annual Meeting of the Society for Investigative Dermatology
– Based on clinical data from previously completed B-SIMPLE4 pivotal Phase 3 clinical study, berdazimer gel, 10.3% (SB206) can shorten the duration of molluscum infection and increase the chance of clearance by enhancing inflammation of molluscum –
2022-05-16 11:21:03 - Seeking Alpha
Novan, Inc. (NOVN) CEO Paula Brown Stafford on Q1 2022 Results - Earnings Call Transcript
Novan, Inc. (NASDAQ:NOVN ) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Paula Brown Stafford - Chairman, President and Chief Executive Officer John Donofrio - Chief Operating Officer, Novan and President, EPI Health John Gay - Chief Financial Officer Conference Call Participants Jennifer Kim - Cantor Fitzgerald Kemp Dolliver - Brookline Capital John Vandermosten - Zacks Jonathan Aschoff - Roth Capital Partners Operator Hello and welcome to the Novan, Incorporated Quarterly Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.